InMed Pharmaceuticals (INM) Other Operating Expenses (2019 - 2026)
InMed Pharmaceuticals (INM) reported Other Operating Expenses of $74875.0 for Q1 2026, up 21.42% on a YoY basis from $61668.0 in Q1 2025, and up 113.53% quarter-over-quarter from $35065.0 in Q4 2025.
InMed Pharmaceuticals (INM) Other Operating Expenses (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals has reported Other Operating Expenses for 8 years, with the latest figure at $74875.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses rose 21.42% year-over-year to $74875.0; the trailing twelve-month figure through Mar 2026 stood at $240343.0 (up 69.66% YoY), and the FY2025 full-year result was $191106.0, up 166.99% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $74875.0, up from $35065.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $145839.0 in Q3 2022, with the low at -$8.8 million in Q2 2022.
- Historically, Other Operating Expenses has averaged -$672559.2 across 5 years, with a median of $35065.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Operating Expenses slumped 328.49% — and 2024, when it jumped 448.39%.
- InMed Pharmaceuticals' Other Operating Expenses stood at -$23286.0 in 2022, then decreased by 24.71% to -$29040.0 in 2023, then jumped by 405.6% to $88746.0 in 2024, then slumped by 60.49% to $35065.0 in 2025, then soared by 113.53% to $74875.0 in 2026.
- The last three Other Operating Expenses figures came in at $74875.0 (Q1 2026), $35065.0 (Q4 2025), and $110196.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | InMed Pharmaceuticals | 6.04 Mn | 796,124.14 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,875.00 |
| Dec 31, 2025 | 35,065.00 |
| Sep 30, 2025 | 110,196.00 |
| Jun 30, 2025 | 20,207.00 |
| Mar 31, 2025 | 61,668.00 |
| Dec 31, 2024 | 88,746.00 |
| Sep 30, 2024 | 21,683.00 |
| Jun 30, 2024 | -30,438.00 |
| Mar 31, 2024 | 78,935.00 |
| Dec 31, 2023 | -29,040.00 |
| Sep 30, 2023 | 89,450.00 |
| Jun 30, 2023 | 90,582.00 |
| Mar 31, 2023 | 14,394.00 |
| Dec 31, 2022 | -23,286.00 |
| Sep 30, 2022 | 145,839.00 |
| Jun 30, 2022 | -8.79 Mn |
| Mar 31, 2022 | -3.39 Mn |
| Dec 31, 2021 | -4.22 Mn |
| Sep 30, 2021 | 28,532.00 |
| Jun 30, 2021 | -2.05 Mn |